HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) CME: Take the course for this article: QUIZ 1 WORKSHEET: The Staging of Colorectal Cancer: 2004 and B... Submit a letter to the editor View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Compton, C. C. Articles by Greene, F. L. Search for Related Content PubMed PubMed Citation Articles by Compton, C. C. Articles by Greene, F. L.

The Staging of Colorectal Cancer: 2004 and Beyond

Dr. Compton is Chair, Pathology, and Pathologist-in-Chief, McGill University, Montreal, Canada.
Dr. Greene is Chair, Department of General Surgery, Carolinas Medical Center, Charlotte, NC.

Stage is the strongest predictor of survival for patients with colorectal cancer. Accurate staging also is critical for appropriate patient management and meaningful clinical research. Uniform staging criteria applied in a uniform manner are essential for accurate evaluation of therapies and outcomes. Historically, numerous different staging systems for colorectal cancer have been employed, but a single internationally recognized system is required to ensure a common language for cancer that is understood by clinicians in all specialties. For the tumor, node, metastasis system to remain relevant, it has to continuously undergo critical evaluation and change when clinically indicated.

This article has been cited by other articles:

				L. L. Gunderson, J. M. Jessup, D. J. Sargent, F. L. Greene, and A. Stewart Revised Tumor and Node Categorization for Rectal Cancer Based on Surveillance, Epidemiology, and End Results and Rectal Pooled Analysis Outcomes J. Clin. Oncol., January 10, 2010; 28(2): 256 - 263. [Abstract] [Full Text] [PDF]

				L. L. Gunderson, J. M. Jessup, D. J. Sargent, F. L. Greene, and A. K. Stewart Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data J. Clin. Oncol., January 10, 2010; 28(2): 264 - 271. [Abstract] [Full Text] [PDF]

				S. H. Park, S. Y. Kim, S. S. Lee, L. Bogoni, A. Y. Kim, S.-K. Yang, S.-J. Myung, J.-S. Byeon, B. D. Ye, and H. K. Ha Sensitivity of CT Colonography for Nonpolypoid Colorectal Lesions Interpreted by Human Readers and With Computer-Aided Detection Am. J. Roentgenol., July 1, 2009; 193(1): 70 - 78. [Abstract] [Full Text] [PDF]

				H. Q. DOAN, K. A. BOWEN, L. A. JACKSON, and B. M. EVERS Toll-like Receptor 4 Activation Increases Akt Phosphorylation in Colon Cancer Cells Anticancer Res, July 1, 2009; 29(7): 2473 - 2478. [Abstract] [Full Text] [PDF]

				S. A. Waldman, T. Hyslop, S. Schulz, A. Barkun, K. Nielsen, J. Haaf, C. Bonaccorso, Y. Li, and D. S. Weinberg Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer JAMA, February 18, 2009; 301(7): 745 - 752. [Abstract] [Full Text] [PDF]

				A. Di Paolo, M. Lencioni, F. Amatori, S. Di Donato, G. Bocci, C. Orlandini, M. Lastella, F. Federici, M. Iannopollo, A. Falcone, et al. 5-Fluorouracil Pharmacokinetics Predicts Disease-free Survival in Patients Administered Adjuvant Chemotherapy for Colorectal Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2749 - 2755. [Abstract] [Full Text] [PDF]

				A. Sezeur, F.P. Chatelet, Ch. Cywiner, Cl. de Labriolle-Vaylet, C. Chastang, Cl. Billotey, M. Malafosse, D. Gallot, P. Betton, F. Montravers, et al. Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging Clin. Cancer Res., September 15, 2007; 13(18): 5592s - 5597s. [Abstract] [Full Text] [PDF]

				B. M. Wolpin, J. A. Meyerhardt, H. J. Mamon, and R. J. Mayer Adjuvant Treatment of Colorectal Cancer CA Cancer J Clin, May 1, 2007; 57(3): 168 - 185. [Abstract] [Full Text] [PDF]

				E Benzoni, D Intersimone, G Terrosu, V Bresadola, A Cojutti, F Cerato, and C Avellini Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer J. Clin. Pathol., May 1, 2006; 59(5): 505 - 512. [Abstract] [Full Text] [PDF]

				V. R. Adams Evolving role of antineoplastic agents in colorectal cancer Am. J. Health Syst. Pharm., May 1, 2006; 63(9_Supplement_2): S4 - S11. [Abstract] [Full Text] [PDF]

				M. Redston, C. C. Compton, B. W. Miedema, D. Niedzwiecki, J. M. Dowell, S. D. Jewell, J. M. Fleshman, J. Bem, R. J. Mayer, and M. M. Bertagnolli Analysis of Micrometastatic Disease in Sentinel Lymph Nodes From Resectable Colon Cancer: Results of Cancer and Leukemia Group B Trial 80001 J. Clin. Oncol., February 20, 2006; 24(6): 878 - 883. [Abstract] [Full Text] [PDF]

				M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. C. Gatter, A. L. Harris, and for Tumour and Angiogenesis Research Group Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer Clin. Cancer Res., December 15, 2005; 11(24): 8653 - 8660. [Abstract] [Full Text] [PDF]

eLetters: